Skip to main content
Top
Published in: BMC Medical Research Methodology 1/2014

Open Access 01-12-2014 | Research article

External validation of multivariable prediction models: a systematic review of methodological conduct and reporting

Authors: Gary S Collins, Joris A de Groot, Susan Dutton, Omar Omar, Milensu Shanyinde, Abdelouahid Tajar, Merryn Voysey, Rose Wharton, Ly-Mee Yu, Karel G Moons, Douglas G Altman

Published in: BMC Medical Research Methodology | Issue 1/2014

Login to get access

Abstract

Background

Before considering whether to use a multivariable (diagnostic or prognostic) prediction model, it is essential that its performance be evaluated in data that were not used to develop the model (referred to as external validation). We critically appraised the methodological conduct and reporting of external validation studies of multivariable prediction models.

Methods

We conducted a systematic review of articles describing some form of external validation of one or more multivariable prediction models indexed in PubMed core clinical journals published in 2010. Study data were extracted in duplicate on design, sample size, handling of missing data, reference to the original study developing the prediction models and predictive performance measures.

Results

11,826 articles were identified and 78 were included for full review, which described the evaluation of 120 prediction models. in participant data that were not used to develop the model. Thirty-three articles described both the development of a prediction model and an evaluation of its performance on a separate dataset, and 45 articles described only the evaluation of an existing published prediction model on another dataset. Fifty-seven percent of the prediction models were presented and evaluated as simplified scoring systems. Sixteen percent of articles failed to report the number of outcome events in the validation datasets. Fifty-four percent of studies made no explicit mention of missing data. Sixty-seven percent did not report evaluating model calibration whilst most studies evaluated model discrimination. It was often unclear whether the reported performance measures were for the full regression model or for the simplified models.

Conclusions

The vast majority of studies describing some form of external validation of a multivariable prediction model were poorly reported with key details frequently not presented. The validation studies were characterised by poor design, inappropriate handling and acknowledgement of missing data and one of the most key performance measures of prediction models i.e. calibration often omitted from the publication. It may therefore not be surprising that an overwhelming majority of developed prediction models are not used in practice, when there is a dearth of well-conducted and clearly reported (external validation) studies describing their performance on independent participant data.
Appendix
Available only for authorised users
Literature
1.
go back to reference Collins GS, Mallett S, Omar O, Yu LM: Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011, 9: 103-10.1186/1741-7015-9-103.CrossRefPubMedPubMedCentral Collins GS, Mallett S, Omar O, Yu LM: Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting. BMC Med. 2011, 9: 103-10.1186/1741-7015-9-103.CrossRefPubMedPubMedCentral
2.
go back to reference Mallett S, Royston P, Dutton S, Waters R, Altman DG: Reporting methods in studies developing prognostic models in cancer: a review. BMC Med. 2010, 8: 20-10.1186/1741-7015-8-20.CrossRefPubMedPubMedCentral Mallett S, Royston P, Dutton S, Waters R, Altman DG: Reporting methods in studies developing prognostic models in cancer: a review. BMC Med. 2010, 8: 20-10.1186/1741-7015-8-20.CrossRefPubMedPubMedCentral
3.
go back to reference Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW: An updated catalog of prostate cancer predictive tools. Cancer. 2008, 113: 3075-3099. 10.1002/cncr.23908.CrossRefPubMed Shariat SF, Karakiewicz PI, Roehrborn CG, Kattan MW: An updated catalog of prostate cancer predictive tools. Cancer. 2008, 113: 3075-3099. 10.1002/cncr.23908.CrossRefPubMed
4.
go back to reference Rabar S, Lau R, O’Flynn N, Li L, Barry P, Guideline Development Group: Risk assessment of fragility fractures: summary of NICE guidance. BMJ. 2012, 345: e3698-10.1136/bmj.e3698.CrossRefPubMed Rabar S, Lau R, O’Flynn N, Li L, Barry P, Guideline Development Group: Risk assessment of fragility fractures: summary of NICE guidance. BMJ. 2012, 345: e3698-10.1136/bmj.e3698.CrossRefPubMed
5.
go back to reference Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, op Reimer WJ S, Vrints C, Wood D, Zamorano JL, Zannad F: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012, 33: 1635-1701.CrossRefPubMed Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, op Reimer WJ S, Vrints C, Wood D, Zamorano JL, Zannad F: European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012, 33: 1635-1701.CrossRefPubMed
6.
go back to reference Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA: American association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary. Endocr Pract. 2012, 18: 269-293. 10.4158/EP.18.2.269.CrossRefPubMed Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, Shepherd MD, Seibel JA: American association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: executive summary. Endocr Pract. 2012, 18: 269-293. 10.4158/EP.18.2.269.CrossRefPubMed
7.
go back to reference Kattan MW, Yu C, Stephenson AJ, Sartor O, Tombal B: Clinicians versus nomogram: predicting future technetium-99 m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer. Urology. 2013, 81: 956-961. 10.1016/j.urology.2012.12.010.CrossRefPubMed Kattan MW, Yu C, Stephenson AJ, Sartor O, Tombal B: Clinicians versus nomogram: predicting future technetium-99 m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer. Urology. 2013, 81: 956-961. 10.1016/j.urology.2012.12.010.CrossRefPubMed
8.
go back to reference Ross PL, Gerigk C, Gonen M, Yossepowitch O, Cagiannos I, Sogani PC, Scardino PT, Kattan MW: Comparisons of nomograms and urologists’ predictions in prostate cancer. Semin Urol Oncol. 2002, 20: 82-88. 10.1053/suro.2002.32490.CrossRefPubMed Ross PL, Gerigk C, Gonen M, Yossepowitch O, Cagiannos I, Sogani PC, Scardino PT, Kattan MW: Comparisons of nomograms and urologists’ predictions in prostate cancer. Semin Urol Oncol. 2002, 20: 82-88. 10.1053/suro.2002.32490.CrossRefPubMed
9.
go back to reference Vickers AJ, Cronin AM: Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology. 2010, 76 (6): 1298-1301. 10.1016/j.urology.2010.06.019.CrossRefPubMedPubMedCentral Vickers AJ, Cronin AM: Everything you always wanted to know about evaluating prediction models (but were too afraid to ask). Urology. 2010, 76 (6): 1298-1301. 10.1016/j.urology.2010.06.019.CrossRefPubMedPubMedCentral
10.
go back to reference Chalmers I, Glasziou P: Avoidable waste in the production and reporting of research evidence. Lancet. 2009, 374: 86-89. 10.1016/S0140-6736(09)60329-9.CrossRefPubMed Chalmers I, Glasziou P: Avoidable waste in the production and reporting of research evidence. Lancet. 2009, 374: 86-89. 10.1016/S0140-6736(09)60329-9.CrossRefPubMed
11.
go back to reference Steyerberg EW, Moons KGM, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG: Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013, 10 (2): e1001381-10.1371/journal.pmed.1001381.CrossRefPubMedPubMedCentral Steyerberg EW, Moons KGM, van der Windt DA, Hayden JA, Perel P, Schroter S, Riley RD, Hemingway H, Altman DG: Prognosis Research Strategy (PROGRESS) 3: prognostic model research. PLoS Med. 2013, 10 (2): e1001381-10.1371/journal.pmed.1001381.CrossRefPubMedPubMedCentral
12.
go back to reference Altman DG, Vergouwe Y, Royston P, Moons KGM: Prognosis and prognostic research: validating a prognostic model. BMJ. 2009, 338: b605-10.1136/bmj.b605.CrossRefPubMed Altman DG, Vergouwe Y, Royston P, Moons KGM: Prognosis and prognostic research: validating a prognostic model. BMJ. 2009, 338: b605-10.1136/bmj.b605.CrossRefPubMed
13.
go back to reference Altman DG, Royston P: What do we mean by validating a prognostic model?. Stat Med. 2000, 19 (4): 453-473. 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5.CrossRefPubMed Altman DG, Royston P: What do we mean by validating a prognostic model?. Stat Med. 2000, 19 (4): 453-473. 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5.CrossRefPubMed
14.
go back to reference Steyerberg EW: Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. 2009, New York: SpringerCrossRef Steyerberg EW: Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating. 2009, New York: SpringerCrossRef
15.
go back to reference Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010, 21 (1): 128-138. 10.1097/EDE.0b013e3181c30fb2.CrossRefPubMedPubMedCentral Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, Obuchowski N, Pencina MJ, Kattan MW: Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology. 2010, 21 (1): 128-138. 10.1097/EDE.0b013e3181c30fb2.CrossRefPubMedPubMedCentral
16.
go back to reference Kuehn MB: Striving for a more perfect peer review editors confront strengths, flaws of biomedical literature. JAMA. 2013, 310: 1781-1783. 10.1001/jama.2013.280660.CrossRefPubMed Kuehn MB: Striving for a more perfect peer review editors confront strengths, flaws of biomedical literature. JAMA. 2013, 310: 1781-1783. 10.1001/jama.2013.280660.CrossRefPubMed
17.
go back to reference Boutron I, Dutton S, Ravaud P, Altman DG: Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010, 303: 2058-2064. 10.1001/jama.2010.651.CrossRefPubMed Boutron I, Dutton S, Ravaud P, Altman DG: Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010, 303: 2058-2064. 10.1001/jama.2010.651.CrossRefPubMed
18.
go back to reference Ochodo EA, de Haan MC, Reitsma JB, Hooft L, Bossuyt PM, Leeflang MM: Overinterpretation and misreporting of diagnostic accuracy studies: evidence of “spin”. Radiology. 2013, 267: 581-588. 10.1148/radiol.12120527.CrossRefPubMed Ochodo EA, de Haan MC, Reitsma JB, Hooft L, Bossuyt PM, Leeflang MM: Overinterpretation and misreporting of diagnostic accuracy studies: evidence of “spin”. Radiology. 2013, 267: 581-588. 10.1148/radiol.12120527.CrossRefPubMed
19.
go back to reference Ioannidis JPA, Khoury MJ: Improving validation practices in “Omics” research. Science. 2011, 334: 1230-1232. 10.1126/science.1211811.CrossRefPubMed Ioannidis JPA, Khoury MJ: Improving validation practices in “Omics” research. Science. 2011, 334: 1230-1232. 10.1126/science.1211811.CrossRefPubMed
20.
go back to reference Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R: Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014, 383: 166-175. 10.1016/S0140-6736(13)62227-8.CrossRefPubMedPubMedCentral Ioannidis JP, Greenland S, Hlatky MA, Khoury MJ, Macleod MR, Moher D, Schulz KF, Tibshirani R: Increasing value and reducing waste in research design, conduct, and analysis. Lancet. 2014, 383: 166-175. 10.1016/S0140-6736(13)62227-8.CrossRefPubMedPubMedCentral
21.
go back to reference Ioannidis JPA: Scientific inbreeding and same-team replication: type D personality as an example. J Psychosom Res. 2012, 73: 408-410. 10.1016/j.jpsychores.2012.09.014.CrossRefPubMed Ioannidis JPA: Scientific inbreeding and same-team replication: type D personality as an example. J Psychosom Res. 2012, 73: 408-410. 10.1016/j.jpsychores.2012.09.014.CrossRefPubMed
22.
go back to reference Collins GS, Omar O, Shanyinde M, Yu LM: A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol. 2013, 66: 268-277. 10.1016/j.jclinepi.2012.06.020.CrossRefPubMed Collins GS, Omar O, Shanyinde M, Yu LM: A systematic review finds prediction models for chronic kidney were poorly reported and often developed using inappropriate methods. J Clin Epidemiol. 2013, 66: 268-277. 10.1016/j.jclinepi.2012.06.020.CrossRefPubMed
23.
go back to reference Bouwmeester W, Zuithoff NP, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, Altman DG, Moons KG: Reporting and methods in clinical prediction research: a systematic review. PLoS Med. 2012, 9 (5): e1001221-10.1371/journal.pmed.1001221.CrossRefPubMedCentral Bouwmeester W, Zuithoff NP, Mallett S, Geerlings MI, Vergouwe Y, Steyerberg EW, Altman DG, Moons KG: Reporting and methods in clinical prediction research: a systematic review. PLoS Med. 2012, 9 (5): e1001221-10.1371/journal.pmed.1001221.CrossRefPubMedCentral
24.
go back to reference Jaja BN, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneaux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Singh J, Macdonald RL: Clinical prediction models for aneurysmal subarachnoid hemorrhage: a systematic review. Neurocrit Care. 2013, 18 (1): 143-153. 10.1007/s12028-012-9792-z.CrossRefPubMed Jaja BN, Cusimano MD, Etminan N, Hanggi D, Hasan D, Ilodigwe D, Lantigua H, Le Roux P, Lo B, Louffat-Olivares A, Mayer S, Molyneaux A, Quinn A, Schweizer TA, Schenk T, Spears J, Todd M, Torner J, Vergouwen MD, Wong GK, Singh J, Macdonald RL: Clinical prediction models for aneurysmal subarachnoid hemorrhage: a systematic review. Neurocrit Care. 2013, 18 (1): 143-153. 10.1007/s12028-012-9792-z.CrossRefPubMed
25.
go back to reference Steyerberg EW, Harrell FE, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, Habbema JDF: Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001, 54: 774-781. 10.1016/S0895-4356(01)00341-9.CrossRefPubMed Steyerberg EW, Harrell FE, Borsboom GJJM, Eijkemans MJC, Vergouwe Y, Habbema JDF: Internal validation of predictive models: efficiency of some procedures for logistic regression analysis. J Clin Epidemiol. 2001, 54: 774-781. 10.1016/S0895-4356(01)00341-9.CrossRefPubMed
26.
go back to reference Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M: Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012, 98: 691-698. 10.1136/heartjnl-2011-301247.CrossRefPubMed Moons KG, Kengne AP, Grobbee DE, Royston P, Vergouwe Y, Altman DG, Woodward M: Risk prediction models: II. External validation, model updating, and impact assessment. Heart. 2012, 98: 691-698. 10.1136/heartjnl-2011-301247.CrossRefPubMed
27.
go back to reference Mallett S, Royston P, Waters R, Dutton S, Altman DG: Reporting performance of prognostic models in cancer: a review. BMC Med. 2010, 8: 21-10.1186/1741-7015-8-21.CrossRefPubMedPubMedCentral Mallett S, Royston P, Waters R, Dutton S, Altman DG: Reporting performance of prognostic models in cancer: a review. BMC Med. 2010, 8: 21-10.1186/1741-7015-8-21.CrossRefPubMedPubMedCentral
28.
go back to reference Vergouwe Y, Steyerberg EW, Eijkemans MJC, Habbema JDF: Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol. 2005, 58 (5): 475-483. 10.1016/j.jclinepi.2004.06.017.CrossRefPubMed Vergouwe Y, Steyerberg EW, Eijkemans MJC, Habbema JDF: Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol. 2005, 58 (5): 475-483. 10.1016/j.jclinepi.2004.06.017.CrossRefPubMed
29.
go back to reference Burton A, Altman DG: Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer. 2004, 91 (1): 4-8. 10.1038/sj.bjc.6601907.CrossRefPubMedPubMedCentral Burton A, Altman DG: Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines. Br J Cancer. 2004, 91 (1): 4-8. 10.1038/sj.bjc.6601907.CrossRefPubMedPubMedCentral
30.
go back to reference Janssen KJ, Donders AR, Harrell FE, Vergouwe Y, Chen Q, Grobbee DE, Moons KG: Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010, 63 (7): 721-727. 10.1016/j.jclinepi.2009.12.008.CrossRefPubMed Janssen KJ, Donders AR, Harrell FE, Vergouwe Y, Chen Q, Grobbee DE, Moons KG: Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol. 2010, 63 (7): 721-727. 10.1016/j.jclinepi.2009.12.008.CrossRefPubMed
31.
go back to reference White IR, Royston P, Wood AM: Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011, 30 (4): 377-399. 10.1002/sim.4067.CrossRefPubMed White IR, Royston P, Wood AM: Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011, 30 (4): 377-399. 10.1002/sim.4067.CrossRefPubMed
32.
go back to reference Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI, Kern LM: Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009, 151: 775-783. 10.7326/0003-4819-151-11-200912010-00005.CrossRefPubMedPubMedCentral Bang H, Edwards AM, Bomback AS, Ballantyne CM, Brillon D, Callahan MA, Teutsch SM, Mushlin AI, Kern LM: Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med. 2009, 151: 775-783. 10.7326/0003-4819-151-11-200912010-00005.CrossRefPubMedPubMedCentral
33.
go back to reference Tang EW, Wong CK, Herbison P: Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007, 153: 29-35. 10.1016/j.ahj.2006.10.004.CrossRefPubMed Tang EW, Wong CK, Herbison P: Global Registry of Acute Coronary Events (GRACE) hospital discharge risk score accurately predicts long-term mortality post acute coronary syndrome. Am Heart J. 2007, 153: 29-35. 10.1016/j.ahj.2006.10.004.CrossRefPubMed
34.
go back to reference Royston P, Altman DG: External validation of a cox prognostic model: principles and methods. BMC Med Res Methodol. 2013, 13 (1): 33-10.1186/1471-2288-13-33.CrossRefPubMedPubMedCentral Royston P, Altman DG: External validation of a cox prognostic model: principles and methods. BMC Med Res Methodol. 2013, 13 (1): 33-10.1186/1471-2288-13-33.CrossRefPubMedPubMedCentral
35.
go back to reference Bleeker SE, Moll HA, Steyerberg EW, Donders ART, Derksen-Lubsen G, Grobbee DE, Moons KGM: External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003, 56 (9): 826-832. 10.1016/S0895-4356(03)00207-5.CrossRefPubMed Bleeker SE, Moll HA, Steyerberg EW, Donders ART, Derksen-Lubsen G, Grobbee DE, Moons KGM: External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003, 56 (9): 826-832. 10.1016/S0895-4356(03)00207-5.CrossRefPubMed
36.
go back to reference Collins GS, Mallett S, Altman DG: Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ. 2011, 342: d3651-10.1136/bmj.d3651.CrossRefPubMedPubMedCentral Collins GS, Mallett S, Altman DG: Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores. BMJ. 2011, 342: d3651-10.1136/bmj.d3651.CrossRefPubMedPubMedCentral
37.
go back to reference Collins GS, Michaëlsson K: Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?. Curr Osteoporos Rep. 2013, 10: 199-207.CrossRef Collins GS, Michaëlsson K: Fracture risk assessment: state of the art, methodologically unsound, or poorly reported?. Curr Osteoporos Rep. 2013, 10: 199-207.CrossRef
39.
go back to reference Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Krieg MA HD, La Croix A, McCloskey E, Mellstrom D, Melton LJ, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007, 18: 1033-1046. 10.1007/s00198-007-0343-y.CrossRefPubMed Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, Burckhardt P, Cooper C, Christiansen C, Cummings S, Eisman JA, Fujiwara S, Gluer C, Goltzman D, Krieg MA HD, La Croix A, McCloskey E, Mellstrom D, Melton LJ, Pols H, Reeve J, Sanders K, Schott AM, Silman A, Torgerson D, van Staa T, Watts NB, Yoshimura N: The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int. 2007, 18: 1033-1046. 10.1007/s00198-007-0343-y.CrossRefPubMed
40.
go back to reference Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009, 338: b2393-10.1136/bmj.b2393.CrossRefPubMedPubMedCentral Sterne JAC, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, Wood AM, Carpenter JR: Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009, 338: b2393-10.1136/bmj.b2393.CrossRefPubMedPubMedCentral
41.
go back to reference Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, Petersen I: Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf. 2010, 19 (6): 618-626. 10.1002/pds.1934.CrossRefPubMed Marston L, Carpenter JR, Walters KR, Morris RW, Nazareth I, Petersen I: Issues in multiple imputation of missing data for large general practice clinical databases. Pharmacoepidemiol Drug Saf. 2010, 19 (6): 618-626. 10.1002/pds.1934.CrossRefPubMed
42.
go back to reference Casarett DJ, Farrington S, Craig T, Slattery J, Harrold J, Oldanie B, Roy J, Biehl R, Teno J: The art versus science of predicting prognosis: can a prognostic index predict short-term mortality better than experienced nurses do?. J Palliat Med. 2012, 15 (6): 703-708. 10.1089/jpm.2011.0531.CrossRefPubMedPubMedCentral Casarett DJ, Farrington S, Craig T, Slattery J, Harrold J, Oldanie B, Roy J, Biehl R, Teno J: The art versus science of predicting prognosis: can a prognostic index predict short-term mortality better than experienced nurses do?. J Palliat Med. 2012, 15 (6): 703-708. 10.1089/jpm.2011.0531.CrossRefPubMedPubMedCentral
43.
go back to reference Groenwold RH, Donders AR, Roes KC, Harrell FE, Moons KG: Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012, 175 (3): 210-217. 10.1093/aje/kwr302.CrossRefPubMed Groenwold RH, Donders AR, Roes KC, Harrell FE, Moons KG: Dealing with missing outcome data in randomized trials and observational studies. Am J Epidemiol. 2012, 175 (3): 210-217. 10.1093/aje/kwr302.CrossRefPubMed
44.
go back to reference Vergouw D, Heymans MW, van der Windt DA, Foster NE, Dunn KM, van der Horst HE, de Vet HC: Missing data and imputation: a practical illustration in a prognostic study on low back pain. J Manipulative Physiol Ther. 2012, 35 (6): 464-471. 10.1016/j.jmpt.2012.07.002.CrossRefPubMed Vergouw D, Heymans MW, van der Windt DA, Foster NE, Dunn KM, van der Horst HE, de Vet HC: Missing data and imputation: a practical illustration in a prognostic study on low back pain. J Manipulative Physiol Ther. 2012, 35 (6): 464-471. 10.1016/j.jmpt.2012.07.002.CrossRefPubMed
46.
go back to reference Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE: Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio) marker. Heart. 2012, 98: 683-690. 10.1136/heartjnl-2011-301246.CrossRefPubMed Moons KG, Kengne AP, Woodward M, Royston P, Vergouwe Y, Altman DG, Grobbee DE: Risk prediction models: I. Development, internal validation, and assessing the incremental value of a new (bio) marker. Heart. 2012, 98: 683-690. 10.1136/heartjnl-2011-301246.CrossRefPubMed
47.
go back to reference Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, Rigatto C, Uhlig K, Kent DM, Levey AS: Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013, 158: 596-603. 10.7326/0003-4819-158-8-201304160-00004.CrossRefPubMed Tangri N, Kitsios GD, Inker LA, Griffith J, Naimark DM, Walker S, Rigatto C, Uhlig K, Kent DM, Levey AS: Risk prediction models for patients with chronic kidney disease: a systematic review. Ann Intern Med. 2013, 158: 596-603. 10.7326/0003-4819-158-8-201304160-00004.CrossRefPubMed
48.
go back to reference Kramer AA, Zimmerman JE: Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007, 35 (9): 2052-2056. 10.1097/01.CCM.0000275267.64078.B0.CrossRefPubMed Kramer AA, Zimmerman JE: Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007, 35 (9): 2052-2056. 10.1097/01.CCM.0000275267.64078.B0.CrossRefPubMed
49.
go back to reference Moons KGM, Altman DG, Vergouwe Y, Royston P: Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009, 338: b606-10.1136/bmj.b606.CrossRefPubMed Moons KGM, Altman DG, Vergouwe Y, Royston P: Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ. 2009, 338: b606-10.1136/bmj.b606.CrossRefPubMed
50.
go back to reference Vickers AJ, Elkin EB: Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26 (6): 565-574. 10.1177/0272989X06295361.CrossRefPubMedPubMedCentral Vickers AJ, Elkin EB: Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006, 26 (6): 565-574. 10.1177/0272989X06295361.CrossRefPubMedPubMedCentral
51.
go back to reference Baker SG, Cook NR, Vickers A, Kramer BS: Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc. 2009, 172: 729-748. 10.1111/j.1467-985X.2009.00592.x.CrossRefPubMedPubMedCentral Baker SG, Cook NR, Vickers A, Kramer BS: Using relative utility curves to evaluate risk prediction. J R Stat Soc Ser A Stat Soc. 2009, 172: 729-748. 10.1111/j.1467-985X.2009.00592.x.CrossRefPubMedPubMedCentral
52.
go back to reference Vickers AJ, Cronin AM, Aus G, Pihl CG, Becker C, Pettersson K, Scardino PT, Hugosson J, Lilja H: Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden. Cancer. 2010, 116 (11): 2612-2620.PubMedPubMedCentral Vickers AJ, Cronin AM, Aus G, Pihl CG, Becker C, Pettersson K, Scardino PT, Hugosson J, Lilja H: Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden. Cancer. 2010, 116 (11): 2612-2620.PubMedPubMedCentral
53.
go back to reference Geersing GJ, Bouwmeester W, Zuithoff P, Spijker R, Leeflang M, Moons K: Search filters for finding prognostic and diagnostic prediction studies in medline to enhance systematic reviews. PLoS One. 2012, 7 (2): e32844-10.1371/journal.pone.0032844.CrossRefPubMedPubMedCentral Geersing GJ, Bouwmeester W, Zuithoff P, Spijker R, Leeflang M, Moons K: Search filters for finding prognostic and diagnostic prediction studies in medline to enhance systematic reviews. PLoS One. 2012, 7 (2): e32844-10.1371/journal.pone.0032844.CrossRefPubMedPubMedCentral
54.
55.
go back to reference Wilczynski NL, Haynes RB: Optimal search strategies for detecting clinically sound prognostic studies in EMBASE: an analytic survery. J Am Med Inform Assoc. 2005, 12 (4): 481-485. 10.1197/jamia.M1752.CrossRefPubMedPubMedCentral Wilczynski NL, Haynes RB: Optimal search strategies for detecting clinically sound prognostic studies in EMBASE: an analytic survery. J Am Med Inform Assoc. 2005, 12 (4): 481-485. 10.1197/jamia.M1752.CrossRefPubMedPubMedCentral
56.
go back to reference Ettema RG, Peelen LM, Schuurmans MJ, Nierich AP, Kalkman CJ, Moons KG: Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study. Circulation. 2010, 122 (7): 682-689. 10.1161/CIRCULATIONAHA.109.926808. 687 p following p 689CrossRefPubMed Ettema RG, Peelen LM, Schuurmans MJ, Nierich AP, Kalkman CJ, Moons KG: Prediction models for prolonged intensive care unit stay after cardiac surgery: systematic review and validation study. Circulation. 2010, 122 (7): 682-689. 10.1161/CIRCULATIONAHA.109.926808. 687 p following p 689CrossRefPubMed
57.
go back to reference Echouffo-Tcheugui JB, Kengne AP: Risk models to predict chronic kidney disease and its progression: a systematic review. PLoS Med. 2012, 9 (11): e1001344-10.1371/journal.pmed.1001344.CrossRefPubMedPubMedCentral Echouffo-Tcheugui JB, Kengne AP: Risk models to predict chronic kidney disease and its progression: a systematic review. PLoS Med. 2012, 9 (11): e1001344-10.1371/journal.pmed.1001344.CrossRefPubMedPubMedCentral
58.
go back to reference Shariat SF, Karakiewicz PI, Margulis V, Kattan MW: Inventory of prostate cancer predictive tools. Curr Opin Urol. 2008, 18: 279-296. 10.1097/MOU.0b013e3282f9b3e5.CrossRefPubMed Shariat SF, Karakiewicz PI, Margulis V, Kattan MW: Inventory of prostate cancer predictive tools. Curr Opin Urol. 2008, 18: 279-296. 10.1097/MOU.0b013e3282f9b3e5.CrossRefPubMed
59.
go back to reference Steurer J, Haller C, Hauselmann H, Brunner F, Bachmann LM: Clinical value of prognostic instruments to identify patients with an increased risk for osteoporotic fractures: systematic review. PLoS One. 2011, 6 (5): e19994-10.1371/journal.pone.0019994.CrossRefPubMedPubMedCentral Steurer J, Haller C, Hauselmann H, Brunner F, Bachmann LM: Clinical value of prognostic instruments to identify patients with an increased risk for osteoporotic fractures: systematic review. PLoS One. 2011, 6 (5): e19994-10.1371/journal.pone.0019994.CrossRefPubMedPubMedCentral
60.
go back to reference Debray TP, Koffijberg H, Vergouwe Y, Moons KG, Steyerberg EW: Aggregating published prediction models with individual participant data: a comparison of different approaches. Stat Med. 2012, 31: 2697-2712. 10.1002/sim.5412.CrossRefPubMed Debray TP, Koffijberg H, Vergouwe Y, Moons KG, Steyerberg EW: Aggregating published prediction models with individual participant data: a comparison of different approaches. Stat Med. 2012, 31: 2697-2712. 10.1002/sim.5412.CrossRefPubMed
61.
go back to reference Debray TP, Moons KG, Ahmed I, Koffijberg H, Riley RD: A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis. Stat Med. 2013, 32: 3158-3180. 10.1002/sim.5732.CrossRefPubMed Debray TP, Moons KG, Ahmed I, Koffijberg H, Riley RD: A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis. Stat Med. 2013, 32: 3158-3180. 10.1002/sim.5732.CrossRefPubMed
Metadata
Title
External validation of multivariable prediction models: a systematic review of methodological conduct and reporting
Authors
Gary S Collins
Joris A de Groot
Susan Dutton
Omar Omar
Milensu Shanyinde
Abdelouahid Tajar
Merryn Voysey
Rose Wharton
Ly-Mee Yu
Karel G Moons
Douglas G Altman
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medical Research Methodology / Issue 1/2014
Electronic ISSN: 1471-2288
DOI
https://doi.org/10.1186/1471-2288-14-40

Other articles of this Issue 1/2014

BMC Medical Research Methodology 1/2014 Go to the issue